Get the Stockscreener App
1.65
2.48%
0.04
Pre-market:
1.64
-0.01
-0.61%
60 Degrees Pharmaceuticals Inc stock is traded at $1.65, with a volume of 46,067.
It is up +2.48% in the last 24 hours and down -11.29% over the past month.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
See More
Previous Close:
$1.61
Open:
$1.64
24h Volume:
46,067
Relative Volume:
0.04
Market Cap:
$4.35M
Revenue:
$1.41M
Net Income/Loss:
$-7.36M
P/E Ratio:
-0.156
EPS:
-10.5747
Net Cash Flow:
$-7.07M
1W Performance:
+3.12%
1M Performance:
-11.29%
6M Performance:
-68.27%
1Y Performance:
-82.59%
1-Day Range:
$1.57
$1.656
1-Week Range:
$1.55
$1.70
52-Week Range:
$1.29
$14.68
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Name
60 Degrees Pharmaceuticals Inc
Sector
Industry
Phone
202-327-5422
Address
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.65 | 4.35M | 1.41M | -7.36M | -7.07M | -10.57 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News
60 Degrees Pharmaceuticals (SXTP) price target decreased by 19.89% to 14.38 - MSN
60 Degrees Pharmaceuticals and Fathom Holdings Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Quantisnow
60 Degrees Pharmaceuticals Inc. (SXTP) upgraded to buy: Here's what you should know - MSN
Analysts Are Bullish on Top Healthcare Stocks: IGC Pharma (IGC), 60 Degrees Pharmaceuticals, Inc. (SXTP) - The Globe and Mail
60 Degrees Pharma announces 1-for-4 reverse stock split; shares up - MSN
60 Degrees Pharmaceuticals shares slide after Nasdaq flags delisting risk - MSN
Is 60 Degrees (SXTP) stock holding key zones | Q4 2025: EPS Misses ViewsNCAV - Newser
60 Degrees (SXTP) Stock: Investment Potential Review (Tick Up) 2026-04-20Trending Entry Points - UBND thành phố Hải Phòng
60 Degrees Pharmaceuticals, Inc. Partners with Runway Health to Offer ARAKODA® for Convenient Online Malaria Prevention - Quiver Quantitative
60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website - The Manila Times
Once-weekly malaria preventive moves online for U.S. travelers - Stock Titan
SXTP Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
60 Degrees Pharmaceuticals, Inc. Warrant (SXTPW) - Minichart
Sentiment Review: Is 60 Degrees Pharmaceuticals Inc Equity Warrant impacted by rising ratesMarket Performance Recap & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Targets Report: Will 60 Degrees Pharmaceuticals Inc benefit from sector rotationIPO Watch & Weekly Breakout Watchlists - baoquankhu1.vn
Macro Review: Whats the fair value of 60 Degrees Pharmaceuticals Inc stockEarnings Growth Summary & Weekly Market Pulse Alerts - baoquankhu1.vn
SXTPW | 60 Degrees Pharmaceuticals, Inc. Insider Trading - Quiver Quantitative
Is 60 Degrees (SXTP) Stock in a Downtrend | Price at $1.71, Down 4.75%Crowd Entry Signals - Newser
CEO Change: Is 60 Degrees Pharmaceuticals Inc Equity Warrant part of any major index2026 AllTime Highs & Verified High Yield Trade Plans - baoquankhu1.vn
60 Degrees Pharmaceuticals Announces 2025 Annual Results - ADVFN
Earnings Miss: Will 60 Degrees Pharmaceuticals Inc Equity Warrant benefit from geopolitical trends2026 Retail & AI Enhanced Trading Signals - baoquankhu1.vn
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Upgraded to Hold at Wall Street Zen - Defense World
60 Degrees Pharmaceuticals Inc. (SXTP) Upgraded to Buy: Here's What You Should Know - sharewise.com
60 Degrees Pharmaceuticals Inc. (SXTP) Receives Buy Rating Upgrade: Key Information You Need - Bitget
Infrastructure Capital and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire
Join 60 Degrees Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on October 22 - Watertown Public Opinion
Analysts Offer Insights on Healthcare Companies: Danaher (DHR), 60 Degrees Pharmaceuticals, Inc. (SXTP) and BridgeBio Pharma (BBIO) - theglobeandmail.com
Portfolio Shifts: Will 60 Degrees Pharmaceuticals Inc outperform small cap indexes2026 Pullbacks & Accurate Buy Signal Alerts - baoquankhu1.vn
Here's Why 60 Degrees Pharmaceuticals Inc. (SXTP) Looks Ripe for Bottom Fishing - Eastern Progress
10-K: FY2025 Annual Report - Moomoo
60 Degrees Pharmaceuticals Reports 65% Increase in FY 2025 Net Product Revenues to $1.0 Million and Operational Developments - Quiver Quantitative
60 Degrees Pharmaceuticals Inc. (SXTP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
New financings back 60 Degrees Pharma (NASDAQ: SXTP) infectious disease pipeline - Stock Titan
Update Recap: Can 60 Degrees Pharmaceuticals Inc continue delivering strong returns2026 Decliners & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
60 Degrees Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
60 Degrees Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Wall Street Recap: How does 60 Degrees Pharmaceuticals Inc score in quality rankings2026 Major Catalysts & Reliable Price Action Trade Plans - baoquankhu1.vn
Movement Recap: How is 60 Degrees Pharmaceuticals Inc managing supply chain issuesPortfolio Gains Summary & Daily Market Momentum Tracking - baoquankhu1.vn
Analyst Calls: Should I hold or sell 60 Degrees Pharmaceuticals Inc nowRisk Management & Reliable Breakout Forecasts - baoquankhu1.vn
Published on: 2026-03-26 13:08:49 - baoquankhu1.vn
Gap Down: Is 60 Degrees Pharmaceuticals Inc Equity Warrant part of any major index2026 Geopolitical Influence & Verified Trade Idea Suggestions - baoquankhu1.vn
Patterns Watch: Is 60 Degrees Pharmaceuticals Inc Equity Warrant impacted by rising ratesEntry Point & Precise Swing Trade Alerts - baoquankhu1.vn
If You Invested $1,000 in 60 degrees pharmaceuticals, Inc. (SXTP) - Stock Titan
Performance Recap: Is 60 Degrees Pharmaceuticals Inc a momentum stock2026 Buyback Activity & Reliable Price Action Trade Plans - baoquankhu1.vn
60 Degrees Updates Affiliate Share Ownership Disclosure Error - The Globe and Mail
Aug Levels: Can 60 Degrees Pharmaceuticals Inc continue delivering strong returns - baoquankhu1.vn
60 Degrees Pharmaceuticals, Inc. Corrects Prospectus Supplement Disclosure in SEC Form 8-K Filing (March 20, 2026) - Minichart
60 Degrees Pharmaceuticals corrects affiliate share counts in prospectus supplement - TradingView
Affiliate share ownership restated by 60 Degrees (NASDAQ: SXTP) - Stock Titan
60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data
Revenue
Net Income
Cash Flow
EPS
60 Degrees Pharmaceuticals Inc Stock (SXTP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DOW GEOFFREY S | President and CEO |
Dec 10 '25 |
Buy |
0.95 |
9,350 |
8,886 |
46,335 |
| DOW GEOFFREY S | President and CEO |
Dec 11 '25 |
Buy |
0.92 |
3,613 |
3,318 |
49,948 |
| XU CHERYL | Director |
Jun 03 '25 |
Buy |
2.88 |
5,000 |
14,410 |
15,816 |
0.14%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):